13
total announcements
526546.BO · 15 min delayed
Choksi Laboratories Ltd
Choksi Laboratories Ltd has submitted newspaper clippings for the notice of its 33rd Annual General Meeting to be held on September 18, 2026, through video conferencing.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has dispatched letters to shareholders whose email addresses are not registered with the company, informing them that the Annual Report for FY 2025-26 and the Notice of the 33rd AGM are available on the company's website.
Choksi Laboratories Ltd
Choksi Laboratories Ltd
Choksi Laboratories Ltd has submitted a notice convening its 33rd Annual General Meeting (AGM) to be held on September 18, 2026, through video conference or other audio-visual means. The meeting will consider the annual report and accounts for the financial year ended March 31, 2026. The notice is in compliance with SEBI regulations.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has informed that the USFDA inspected its central laboratory in Indore and raised 4 observations, which the company is addressing comprehensively.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has submitted a newspaper clipping related to the 33rd Annual General Meeting to be held through video conferencing, as per SEBI regulations.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has published unaudited financial results for the quarter ended 30th June, 2026, as per Regulation 47 of the SEBI (LODR) Regulations 2015.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has announced the reappointment of Ms. Himika Choksi as Whole Time Director for a further period of five years, effective from 01.04.2027, subject to shareholder approval.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has submitted its unaudited financial results for the quarter ended 30th June 2026, which were approved by the Audit Committee and Board of Directors. The results are accompanied by a Limited Review Report from the independent auditor, PRATEEK JAIN & Co.
Choksi Laboratories Ltd
Choksi Laboratories Ltd announced its Board Meeting outcome on August 13, 2026. The Board considered and approved the Unaudited Financial Results for the Quarter ended on June 30, 2026, along with the Limited review report. The Board also decided the date for closure of Register of Members and share transfer Books for the 33rd Annual General Meeting. Other operational, financial, and administrative matters were discussed and necessary resolutions passed.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has scheduled a Board Meeting on 13th August 2026 to consider and approve unaudited financial results for the quarter ended 30th June 2026, appointment of internal auditor, and other matters.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has changed its Registrar and Share Transfer Agent (RTA) from MUFG Intime India Private Limited to Ankit Consultancy Private Limited, effective August 3, 2026. The company has published a notice in the Free Press Journal and Choutha Sansar newspapers on August 4, 2026.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has announced a change in its Registrar and Transfer Agent (RTA) from MUFG Intime India Private Limited to Ankit Consultancy Private Limited, effective August 3, 2026, as per Regulation 30 of SEBI (LODR) 2015.